IP Library Granted Patent US 12,138,226
Granted Patent B2
US 12,138,226 · App. 17/853,159 · Granted Nov 12, 2024

Methods, compositions, and devices for supplying dietary fatty acid needs

Inventors: Alexey L. Margolin (Newton, MA); Robert Gallotto (Newton, MA); Bhami Shenoy (South Grafton, MA)
Assignee: ALCRESTA THERAPEUTICS, INC.
A61J15/0092A23D7/011A23D7/013A23D9/013A23K20/158A23K50/30A23L29/06A23L33/115A23L33/12A23L33/40A61J15/0003A61J15/0026A61K9/0029A61K31/202A61K38/465B65D1/02B65D41/02B65D81/32B65D85/72C12Y301/00A23V2002/00C12Y301/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,138,226
App. No.
17/853,159
Granted
Nov 12, 2024
Kind
B2
Abstract

Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.

Claims (37)

1. A method of preparing a nutritional formula prior to ingestion by a subject, the method comprising:

exposing at least one of milk, infant formula, or enteral formula comprising triglycerides to immobilized lipase to at least partially hydrolyze the triglycerides within the at least one of milk, infant formula, or enteral formula,

wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 60 minutes, prior to ingestion by the subject, and

wherein the immobilized lipase does not form a part of the nutritional formula.

2. The method of claim 1 , wherein the nutritional formula is ready for ingestion by the subject following the exposing step.

3. The method of claim 1 , wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 30 minutes, prior to ingestion by the subject.

4. The method of claim 1 , wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 10 minutes, prior to ingestion by the subject.

5. The method of claim 1 , further comprising separating the immobilized lipase from the milk, infant formula, or enteral formula, after the exposing step.

6. The method of claim 1 , wherein the immobilized lipase is immobilized to particles.

7. The method of claim 6 , wherein the particles are balls or beads.

8. The method of claim 1 , wherein the immobilized lipase is immobilized within a portion of a device.

9. The method of claim 8 , wherein the device includes a mesh allowing for movement of the milk, infant formula, or enteral formula into and out of the device, while preventing the immobilized lipase from flowing out of the device.

10. The method of claim 9 , wherein the exposing step includes placing the device into a container, wherein the milk, infant formula, or enteral formula is present in the container.

11. The method of claim 10 , wherein after exposure to the immobilized lipase, the milk, infant formula, or enteral formula, comprises more free fatty acids than monoglycerides.

12. A method of preparing a nutritional formula comprising fats in the form of monoglycerides and free fatty acids prior to ingestion by a subject, the method comprising:

exposing at least one of milk, infant formula, or enteral formula comprising triglycerides to an immobilized lipase to form the nutritional formula; and

separating the immobilized lipase and the at least one of milk, infant formula, or enteral formula after the exposing step, wherein the nutritional formula is ready for ingestion by the subject once the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase and the immobilized lipase and the at least one of milk, infant formula, or enteral formula are separated,

wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 60 minutes, prior to ingestion by the subject.

13. The method of claim 12 , wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 30 minutes, prior to ingestion by the subject.

14. The method of claim 12 , wherein the immobilized lipase is immobilized to particles.

15. The method of claim 12 , wherein the immobilized lipase is immobilized within a portion of a device.

16. The method of claim 15 , wherein the device includes a mesh allowing for movement of the at least one of milk, infant formula, or enteral formula into and out of the device, while preventing the immobilized lipase from flowing out of the device.

17. The method of claim 16 , wherein the exposing step includes placing the device into a container, wherein the at least one of milk, infant formula, or enteral formula is present in the container, and wherein the separating step includes removing the device from the container.

18. The method of claim 12 , wherein after exposure to the immobilized lipase, the nutritional formula comprises more free fatty acids than monoglycerides.

19. A method of preparing a nutritional formula comprising fats in the form of monoglycerides and free fatty acids prior to ingestion by a subject, the method comprising:

exposing at least one of milk, infant formula, or enteral formula comprising triglycerides to an immobilized lipase for no more than 30 minutes prior to separating the immobilized lipase and the at least one of milk, infant formula, or enteral formula, wherein the immobilized lipase is immobilized within a device, and wherein the device includes a mesh for allowing movement of the at least one of milk, infant formula, or enteral formula into and out of the device, while preventing the immobilized lipase from flowing out of the device.

20. The method of claim 19 , wherein the immobilized lipase is immobilized to particles.

21. The method of claim 19 , wherein the device is a semi-permeable bag, and the method further comprises placing the device into a container, wherein the at least one of milk, infant formula, or enteral formula is present in the container.

22. The method of claim 19 , wherein after exposure to the immobilized lipase, the nutritional formula comprises more free fatty acids than monoglycerides.

23. A method of preparing a nutritional formula comprising fats in the form of monoglycerides and free fatty acids prior to ingestion by a subject, the method comprising:

exposing at least one of milk, infant formula, or enteral formula comprising triglycerides to an immobilized lipase to form the nutritional formula, wherein the resulting nutritional formula comprises more free fatty acids than monoglycerides,

wherein the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase for no more than 60 minutes, prior to ingestion by the subject,

wherein the immobilized lipase is immobilized within a device, and

wherein the device includes a mesh for allowing movement of the at least one of milk, infant formula, or enteral formula into and out of the device, while preventing the immobilized lipase from flowing out of the device.

24. The method of claim 23 , wherein the immobilized lipase is immobilized to a plurality of particles.

25. The method of claim 23 , wherein the exposing step is performed for no more than 30 minutes, prior to ingestion by the subject.

26. The method of claim 23 , wherein the nutritional formula is ready for ingestion by the subject once the at least one of milk, infant formula, or enteral formula is exposed to the immobilized lipase.

Assignments (3)
SECURITY INTEREST Recorded Mar 12, 2024
From: ALCRESTA THERAPEUTICS, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 066742/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2022
From: MARGOLIN, ALEXEY L; GALLOTTO, ROBERT; SHENOY, BHAMI
To: ALCRESTA, INC.
Reel/Frame 060907/0079 →
CHANGE OF NAME Recorded Jul 25, 2022
From: ALCRESTA, INC.
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 060907/0087 →
Continuity (9)
Continuation 17211487 · Mar 24, 2021
Continuation 16000327 · Jun 5, 2018
Continuation 15684430 · Aug 23, 2017
Continuation 15587513 · May 5, 2017
Continuation 15240596 · Aug 18, 2016
Continuation 14378856
Provisional Application 61719173 · Oct 26, 2012
Provisional Application 61600207 · Feb 17, 2012
Related Publication 20220331207A1 · Oct 20, 2022